Dendreon Corporation (Nasdaq: DNDN) announces updates regarding the commercialization of PROVENGE® (sipuleucel-T).

U.S. CommercializationIn 2010, Dendreon achieved revenues from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE